Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant a » significant _ (Expand Search), significant i (Expand Search), significant gap (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 3,321 - 3,340 results of 17,850 for search '(( significant decrease decrease ) OR ( significant a decrease ))~', query time: 0.35s Refine Results
  1. 3321
    Experimental design.

    Experimental design. by Amy J. Schuh (8520354)

    Published 2025
    Save to List
    Saved in:
  2. 3322
    Effects of SGLT-2is during the time course.

    Effects of SGLT-2is during the time course. by Ningning Wang (560944)

    Published 2025
    Save to List
    Saved in:
  3. 3323
    Volitional control frequency and intensity in VH (Kapsner-Smith et al., 2025)

    Volitional control frequency and intensity in VH (Kapsner-Smith et al., 2025) by Mara R. Kapsner-Smith (22139315)

    Published 2025
    “…<i>Journal of Speech, Language, and Hearing Research, </i><i>68</i>(10), 4736–4748. <a href="https://doi.org/10.1044/2025_JSLHR-25-00182" rel="noreferrer" target="_blank">https://doi.org/10.1044/2025_JSLHR-25-00182</a></p>…”
    Save to List
    Saved in:
  4. 3324
    Characterization of miRNA expression profiles and their potential targets upon Bz and Bz + PTX therapy in chronically infected mice. Relative expression was expressed as fold change (2<sup>-ΔΔCt</sup>). miRNAs with a fold change greater than 1.3 in the vehicle group and at the 0.75–1.3 range (orange striped area) in the Bz and Bz + PTX therapy groups were considered to have a restored expression. They were selected for further analysis on IPA software. (A) The expression of miRNAs was altered in the infected group and an expression was restored after Bz therapy. (B) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (C) Diseases and disorders pathway analysis. (D) The expression of miRNAs was altered in the infected group and restored upon Bz + PTX therapy. (E) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (F) Diseases and disorders pathway analysis. Significant intervals

    Characterization of miRNA expression profiles and their potential targets upon Bz and Bz + PTX therapy in chronically infected mice. Relative expression was expressed as fold chang... by Glaucia Vilar-Pereira (686134)

    Published 2025
    Save to List
    Saved in:
  5. 3325
    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets

    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets by Xinghai Zhong (21450285)

    Published 2025
    “…Additionally, it showed effective self-transport capabilities in the transport experiment with a blood droplet, achieving a transport distance of 25 mm and an average speed of 14.2 mm/s. …”
    Save to List
    Saved in:
  6. 3326
    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets

    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets by Xinghai Zhong (21450285)

    Published 2025
    “…Additionally, it showed effective self-transport capabilities in the transport experiment with a blood droplet, achieving a transport distance of 25 mm and an average speed of 14.2 mm/s. …”
    Save to List
    Saved in:
  7. 3327
    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets

    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets by Xinghai Zhong (21450285)

    Published 2025
    “…Additionally, it showed effective self-transport capabilities in the transport experiment with a blood droplet, achieving a transport distance of 25 mm and an average speed of 14.2 mm/s. …”
    Save to List
    Saved in:
  8. 3328
    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets

    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets by Xinghai Zhong (21450285)

    Published 2025
    “…Additionally, it showed effective self-transport capabilities in the transport experiment with a blood droplet, achieving a transport distance of 25 mm and an average speed of 14.2 mm/s. …”
    Save to List
    Saved in:
  9. 3329
    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets

    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets by Xinghai Zhong (21450285)

    Published 2025
    “…Additionally, it showed effective self-transport capabilities in the transport experiment with a blood droplet, achieving a transport distance of 25 mm and an average speed of 14.2 mm/s. …”
    Save to List
    Saved in:
  10. 3330
    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets

    A Wettability Gradient Synergistic Bionic Wedge-Shaped Track for Ultrafast and Long-Distance Spontaneous Transport of Droplets by Xinghai Zhong (21450285)

    Published 2025
    “…Additionally, it showed effective self-transport capabilities in the transport experiment with a blood droplet, achieving a transport distance of 25 mm and an average speed of 14.2 mm/s. …”
    Save to List
    Saved in:
  11. 3331
    Validation of punch with timestamp: (a) Jab (b) Hook (c) Uppercut.

    Validation of punch with timestamp: (a) Jab (b) Hook (c) Uppercut. by Saravanan Manoharan (21273304)

    Published 2025
    Save to List
    Saved in:
  12. 3332
    The EAPC of ASMR (A), ASDR (B), Age-Standardized Rate of YLDs (C), and Age-Standardized Rate of YLLs (D) of high alcohol use-related Stroke in both sexes combined across 21 GBD regions and SDI regions, 1990–2021.

    The EAPC of ASMR (A), ASDR (B), Age-Standardized Rate of YLDs (C), and Age-Standardized Rate of YLLs (D) of high alcohol use-related Stroke in both sexes combined across 21 GBD reg... by Nannan Qian (10650782)

    Published 2025
    Save to List
    Saved in:
  13. 3333
    Study flow chart.

    Study flow chart. by Raymond Atwine (18574812)

    Published 2025
    “…Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”
    Save to List
    Saved in:
  14. 3334
    Bar graph showing proportion of NADCs.

    Bar graph showing proportion of NADCs. by Raymond Atwine (18574812)

    Published 2025
    “…Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”
    Save to List
    Saved in:
  15. 3335
    Baseline characteristics of study participants.

    Baseline characteristics of study participants. by Raymond Atwine (18574812)

    Published 2025
    “…Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”
    Save to List
    Saved in:
  16. 3336
    Immuno-infiltration analysis.

    Immuno-infiltration analysis. by Wan-Jing Zhen (20427813)

    Published 2024
    Save to List
    Saved in:
  17. 3337
    Rate of missing trials.

    Rate of missing trials. by Tomoe Hayakawa (20978784)

    Published 2025
    Save to List
    Saved in:
  18. 3338
    Task design for measurement of pupillary response.

    Task design for measurement of pupillary response. by Tomoe Hayakawa (20978784)

    Published 2025
    Save to List
    Saved in:
  19. 3339
    Mean and standard error of pupil diameter in the dim states.

    Mean and standard error of pupil diameter in the dim states. by Tomoe Hayakawa (20978784)

    Published 2025
    “…However, in the second experiment (Experiment 2), the pupil diameter in the TD group showed a significant decrease. Significance levels are based on unpaired t-tests (**<i>p</i> <  0.01).…”
    Save to List
    Saved in:
  20. 3340
    Confirmation of NMIIC expression.

    Confirmation of NMIIC expression. by Hiroki Hamaguchi (22783780)

    Published 2025
    Save to List
    Saved in:

Search Tools: